Effects of mutant ubiquitin on ts1 retrovirus-mediated neuropathology

被引:10
作者
Zhang, M
Thurig, S
Tsirigotis, M
Wong, PKY
Reuhl, KR
Gray, DA
机构
[1] Ottawa Reg Canc Ctr, Ctr Canc Therapeut, Ottawa, ON K1H 1C4, Canada
[2] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada
[3] Univ Texas, MD Anderson Canc Ctr, Div Res, Smithville, TX USA
[4] Rutgers State Univ, Dept Pharmacol & Toxicol, Piscataway, NJ 08854 USA
关键词
D O I
10.1128/JVI.77.13.7193-7201.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
ts1 is a temperature-sensitive mutant of Moloney murine leukemia virus that induces a rapid spongiform encephalopathy in mice infected as newborns. The pathological features include the formation of ubiquitinated inclusions resembling Lewy bodies. To determine how perturbation of the ubiquitin-proteasome pathway might affect ts1-mediated neurodegeneration, the virus was introduced into transgenic mice in which the assembly of ubiquitin chains was compromised by the expression of dominant-negative mutant ubiquitin. The onset of symptoms was greatly delayed in a transgenic mouse line expressing K48R mutant ubiquitin; no such delay was observed in mice expressing a wild-type ubiquitin transgene or K63R mutant ubiquitin. The extended latency was found to correlate with a delayed increase in viral titers. Pathological findings in K48R transgenic mice at 60 days were found to be similar to those in the other strains at 30 days, suggesting that while delayed, the neurodegenerative process in K48R mice was otherwise similar. These data demonstrate the sensitivity of retroviral replication to the partial disruption of ubiquitin-mediated proteolysis in vivo, a finding that may have therapeutic potential.
引用
收藏
页码:7193 / 7201
页数:9
相关论文
共 53 条
[1]  
BASZLER TV, 1990, LAB INVEST, V63, P612
[2]  
BROOKS BR, 1980, LAB INVEST, V43, P480
[3]   Tsg101: HIV-1's ticket to ride [J].
Carter, CA .
TRENDS IN MICROBIOLOGY, 2002, 10 (05) :203-205
[4]   SIGNAL-INDUCED SITE-SPECIFIC PHOSPHORYLATION TARGETS I-KAPPA-B-ALPHA TO THE UBIQUITIN-PROTEASOME PATHWAY [J].
CHEN, ZJ ;
HAGLER, J ;
PALOMBELLA, VJ ;
MELANDRI, F ;
SCHERER, D ;
BALLARD, D ;
MANIATIS, T .
GENES & DEVELOPMENT, 1995, 9 (13) :1586-1597
[5]   Neurodegeneration induced by MoMuLV-ts1 and increased expression of Fas and TNF-α in the central nervous system [J].
Choe, WY ;
Stoica, G ;
Lynn, W ;
Wong, PKY .
BRAIN RESEARCH, 1998, 779 (1-2) :1-8
[6]  
Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO
[7]  
2-Q
[8]  
COFFIN JM, 1997, RETROVIRUSES, P277
[9]   Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function [J].
Demirov, DG ;
Ono, A ;
Orenstein, JM ;
Freed, EO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) :955-960
[10]   Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain [J].
Deng, L ;
Wang, C ;
Spencer, E ;
Yang, LY ;
Braun, A ;
You, JX ;
Slaughter, C ;
Pickart, C ;
Chen, ZJ .
CELL, 2000, 103 (02) :351-361